Ching W. Jaw
Net Worth

Last updated:

What is Ching W. Jaw net worth?

The estimated net worth of Mr. Ching W. Jaw is at least $9,390,203 as of 3 Feb 2023. He owns shares worth $2,599,349 as insider, has earned $3,761,604 from insider trading and has received compensation worth at least $3,029,250 in Cytokinetics, Incorporated.

What is the salary of Ching W. Jaw?

Mr. Ching W. Jaw salary is $605,850 per year as Senior Vice President & Chief Financial Officer in Cytokinetics, Incorporated.

How old is Ching W. Jaw?

Mr. Ching W. Jaw is 62 years old, born in 1963.

What stocks does Ching W. Jaw currently own?

As insider, Mr. Ching W. Jaw owns shares in one company:

Company Title Shares Price per share Total value
Cytokinetics, Incorporated (CYTK) Senior Vice President & Chief Financial Officer 67,184 $38.69 $2,599,349

What does Cytokinetics, Incorporated do?

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

CYTK logo
CYTK
Cytokinetics, Incorporated
$38.69

Ching W. Jaw insider trading

Cytokinetics, Incorporated

Mr. Ching W. Jaw has made 7 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 15,000 units of CYTK stock worth $675,000 on 3 Feb 2023.

The largest trade he's ever made was exercising 35,687 units of CYTK stock on 19 Oct 2021. As of 3 Feb 2023 he still owns at least 67,184 units of CYTK stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 15,000 $45 $675,000
Option
Incentive Stock Option (Right to Buy) 15,000 $12.1 $181,500
Option
Common Stock 15,000 $12.1 $181,500
Option
Common Stock 10,000 $12.1 $121,000
Sale
Common Stock 10,000 $42 $420,000
Option
Non-Qualified Stock Option (right to buy) 10,000 $12.1 $121,000
Option
Non-Qualified Stock Option (right to buy) 15,000 $12.1 $181,500
Option
Common Stock 15,000 $12.1 $181,500
Sale
Common Stock 15,000 $40 $600,000
Option
Common Stock 15,000 $12.1 $181,500
Option
Non-Qualified Stock Option (right to buy) 15,000 $12.1 $181,500
Sale
Common Stock 15,000 $38 $570,000
Sale
Common Stock 35,687 $35.73 $1,275,204
Option
Non-Qualified Stock Option (right to buy) 12,500 $30 $375,000
Option
Common Stock 27,500 $24.03 $660,908
Sale
Common Stock 5,000 $30 $150,000
Option
Incentive Stock Option (right to buy) 15,000 $12.1 $181,500
Option
Non-Qualified Stock Option (right to buy) 25,000 $16.07 $401,750
Sale
Common Stock 10,000 $7.14 $71,400
Option
Common Stock 25,000 $16.07 $401,750

Cytokinetics, Incorporated key executives

Cytokinetics, Incorporated executives and other stock owners filed with the SEC: